[1] Kraiklang R, Pairojkul C, Khuntikeo N, et al.A novel predictive equation for potential diagnosis of cholangiocarcinoma. PloS One, 2014, 9:e89337.
[2] Chen QW, Cheng CS, Chen H, et al.Effectiveness and complications of ultrasound guided fine needle aspiration for primary liver cancer in a chinese population with serum α-fetoprotein levels ≤200 ng/ml-a study based on 4,312 patients . PloS One, 2014, 9:e101536.
[3] 钟志敏,王维,莫云丹,等.脱-γ-羧基凝血酶原对原发性肝癌的诊断价值探讨.检验医学,2013,28:382-386.
[4] 石亚玲,江笑文,邝燕玲,等.脱-γ-羧基凝血酶原及甲胎蛋白诊断原发性肝癌的临床价值.中国当代医药,2014,21:73-75.
[5] Tamura Y, Suda T, Arii S, et al. Value of highly sensitive fucosylated fraction of alpha-fetoprotein for prediction of hepatocellular carcinoma recurrence after curative treatment.Dig Dis Sci, 2013, 58:2406-2412.
[6] 刘浩,刘永锋.血甲胎蛋白和脱γ羧基凝血酶原在肝癌患者肝移植适应证选择中的价值.中华器官移植杂志,2013,34:570-572.
[7] Hou SC, Xiao MB, Ni RZ, et al.Serum GP73 is complementary to AFP and GGFⅡ for the dragnosis of hepatocellular carcinoma.Oncol Lett, 2013, 6:1152-1158.
[8] 付水,齐娟飞,朱海燕,等.DCP、AFP-L3和AFP在原发性肝细胞癌诊断中的价值.放射免疫学杂志,2013,26:75-78.
[9] Ching CT, van Hieu N, Cheng TY, et al.Liver Cancer Detection by a Simple, Inexpensive and Effective Immunosensor with Zinc Oxide Nanoparticles . Sensors (Basel), 2015, 15:29408-29418.
[10] 徐飞,牛文彦.甲胎蛋白和甲胎蛋白异质体诊断原发性肝癌的价值.天津医科大学学报,2014,20:475-476.
[11] 王莉,贾志凌,刘畅,等.3种血清肿瘤标志物检测在原发性肝癌诊断中价值.中华实用诊断与治疗杂志,2013,27:759-761.
[12] Okuda Y, Mizuno S, Shiraishi T, et al. Clinicopathological factors affecting survival and recurrence after initial hepatectomy in non-B non-C hepatocellular carcinoma patients with comparison to hepatitis B or C virus. Biomed Res Int, 2014, 2014:975380.
[13] 房萌,高春芳.肝细胞癌诊断标志研究与临床应用新进展.中华检验医学杂志,2013,36:212-216.
[14] Hiraoka A, Ishimaru Y, Kawasaki H, et al. Tumor Markers AFP, AFP-L3, and DCP in Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization. Oncology, 2015, 89:167-174. |
